iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Stock Short Interest Report for October

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) was the target of a large drop in short interest in the month of October. As of October 15th, there was short interest totaling 67,932 shares, a drop of 68.9% from the September 30th total of 218,618 shares. Currently, 0.9% of the company’s stock are sold short. Based on an average daily trading volume, of 164,313 shares, the days-to-cover ratio is currently 0.4 days.

iShares Genomics Immunology and Healthcare ETF Stock Up 2.6%

NYSEARCA IDNA opened at $42.00 on Wednesday. The stock has a market cap of $321.30 million, a PE ratio of 14.76 and a beta of 0.94. iShares Genomics Immunology and Healthcare ETF has a fifty-two week low of $24.29 and a fifty-two week high of $43.44. The business has a 50 day moving average price of $40.55 and a two-hundred day moving average price of $32.99.

Institutional Trading of iShares Genomics Immunology and Healthcare ETF

A hedge fund recently bought a new position in iShares Genomics Immunology and Healthcare ETF stock. NewEdge Advisors LLC bought a new position in shares of iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 961 shares of the company’s stock, valued at approximately $32,000.

iShares Genomics Immunology and Healthcare ETF Company Profile

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.